ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CTSO vs RVP // 10Y YIELD & FRED MACRO BETA

Cytosorbents Corporation (NASDAQ) VS. Retractable Technologies Inc. (NYSE) • 15-METRIC TALLY: CTSO 4 — RVP 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTSO VS. RVP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CTSO RVP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 71.50% 0.10% +71.40 CTSO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -23.30% -11.70 RVP /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -39.80% -55.30% +15.50 CTSO /operating-margins <GO>
Net Profit Margin -22.10% -32.80% +10.70 CTSO /net-margins <GO>
Revenue Growth (YoY) — 15.80% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.52 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.1 25.0 +23.10 CTSO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $14.3M $16.9M -$2.6M RVP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CTSO REV RVP REV CTSO GROSS % RVP GROSS % CTSO FCF RVP FCF
FY 2025 $37.1M $38.3M 71.5% 0.1% -$12.5M -$7.1M
FY 2024 $35.6M $33.0M 69.9% -3.1% -$14.7M -$13.0M
FY 2023 $89.5M $43.6M — — -$21.7M $2.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTSO // BETA —
RVP // BETA —